Zoledronic Acid in Acute Spinal Cord Injury

Drug
Bone health
Online since 16 April 2024, updated 32 days ago

About this trial

Maintenance of bone mass following spinal cord injury (SCI) is essential to fracture prevention and the associated morbidity of bed rest and further secondary complications. Intravenous (IV) zoledroni...

Included participants

Gender
All
Age
18 - 65 years
Injury level
C4 - T10
  • Severity (AIS)?
  • AIS-A
    Time since injury
    ≤ 21 days
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    C4-T10

    What’s involved

    Type

    Drug

    Details

    There are no details yet

    Potential benefits

    Main benefits

    Bone health

    Additional benefits

    General health

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 1 Sep 2012
    • Organisation
    • Thomas Jefferson University
    • Trial recruitment status
    • Ended
    • Trial start date
    • 1 Sep 2012
    • Organisation
    • Thomas Jefferson University

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more